We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The U.S. District Court for the District of Delaware officially dropped the patent infringement litigation concerning a generic version of GlaxoSmithKline's (GSK's) migraine and cluster headache drug Imitrex (sumatriptan succinate), Spectrum Pharmaceuticals announced.
Cardinal Health will pay $11 million to settle an investigation by the New York Attorney General's Office into the purchase and sale of pharmaceutical products on the secondary market, the company announced.
A Canadian court ruling that dismissed an appeal request by Apotex
signals another defeat for the generic drugmaker in its efforts to market generic clopidogrel bisulfate.
Eli Lilly is countering a published report that claims the company's internal data showed a higher rate of diabetes in patients takingits antipsychotic medication Zyprexa than documented in the information provided to doctors.
In observance of the holiday season, FDAnews Drug Daily Bulletin will not be published Monday, Jan. 1. The next issue will be published Tuesday, Jan. 2.
Sanofi pasteur has completed production of more than 170 million doses of influenza vaccine, making it the largest contributor to this year's global supply, the company said.
Northfield Laboratories reported preliminary results from a Phase III clinical trial of its blood substitute, PolyHeme, which showed more deaths among patients using the product than in the control group.
Instead of the new regulatory authority being proposed by lawmakers and embodied in a recent study by the Institute of Medicine, the FDA actually needs money to improve the science of regulation, according to the agency's outgoing deputy commissioner for medical and scientific affairs.
Ortho-McNeil Pharmaceutical has filed a patent infringement lawsuit to stop Barr Laboratories' move to offer a generic version of the epilepsy and migraine drug, Topamax.